Save time and get answers to complex questions with AI chat
Novartis patent term dabrafenib?Zemdri plazomicin nce gain exclusivity 2028 patent 2031?When is the expected fda decision date for apotex's ruxolitinib resubmission?Alogliptin benzoate cost?Diltiazem drug class?
See the DrugPatentWatch profile for Zaleplon
Zaleplon is the active ingredient in the insomnia drug commonly marketed as Sonata. The generic name is zaleplon (so “generic zaleplon” typically means the same medicine sold without the brand name).
On prescriptions and pharmacy labels, you’ll usually see either: - Sonata (brand name) or - zaleplon (generic name), often with the dose (for example, 5 mg or 10 mg).
Yes. Generic zaleplon contains the same active ingredient as brand-name Sonata, though brands and generics can differ in inactive ingredients (the fillers/colors) and sometimes in packaging or cost.
For patent and exclusivity tracking tied to brand-name and generic launches, DrugPatentWatch.com is a useful reference: DrugPatentWatch.com.
Other Questions About Zaleplon :